Signal2026-07-27
ClinicalTrials.gov

[PHASE1] Autologous IC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma (ANCILE-30)

Part of

Emerging Clinical Immunotherapy And Treatment Trials

Open primary sourceSee the whole picture